Price: $500.00 – $2,500.00 (Depending on Gift Card Add-on Selection)
Duration of Access: 1 Year
Quantifiable Deliverables: 100 Hours of AAPA Category 1 CME Credit (PANRE Course), Comprehensive Blueprint Review, and Practice Question Bank.
It’s that time of year again. Your CME allowance is sitting in your hospital’s account like a ticking time bomb. If you don’t spend it by December 31st, it vanishes into the administrative ether, likely to be repurposed for "breakroom upgrades" you’ll never see. As a Physician Assistant, you’ve earned that money through countless hours of patient care, charting, and managing the occasional patient who thinks their Google search is equivalent to your clinical degree.
Spending your CME budget shouldn't feel like a chore. It should feel like a strategic investment in both your career and your sanity. At CME Review Courses, we’ve perfected the art of the "efficient purchase." We offer high-yield PANRE review and pharmacology content paired with gift card add-ons that allow you to upgrade your clinical toolkit: or your living room: simultaneously.
The Strategy: Maximizing the Value of Every CME Dollar
Most CME packages give you a login and a handshake. We give you a login and an Amazon or Apple Gift Card.
Here is how it works: You select your course, choose a gift card add-on ranging from $100 to $1,500, and complete your purchase. You receive your receipt for the total amount, which you then submit to your employer for reimbursement. This is a common practice for PAs and NPs looking to maximize their professional development funds. Whether you need a new iPad for charting (or "charting" in bed), a high-end stethoscope, or just enough Amazon credit to never pay for diapers again, the gift card add-on is the smartest way to handle your allowance.
PANRE Review Course: 100 Hours of Category 1 AAPA Credit
If you are staring down the barrel of the PANRE or the PANRE-LA, you need more than just a quick refresher. Our PANRE Review Course provides 100 hours of AAPA Category 1 CME credit. This content was written by PAs, for PAs. We know the blueprint because we live the blueprint. We cover the high-stakes topics you’ll actually see on the exam:
- Emergency Medicine
- Family Medicine
- Internal Medicine/Hospitalist
- Orthopedics
- Dermatology
- Psychiatry
- Neurology
- Cardiology
- OB/GYN
The Pharmacology Course
For those who need to brush up on their prescribing chops or meet specific state requirements, our Pharmacology Course is the gold standard. It also counts as AAPA Category 1 CME credit. While Nurse Practitioners and Physicians often find immense value in our content, it’s important to note that NPs should check their specific state board requirements for Category 1 AAPA credit acceptance. For physicians, our courses typically count as Category 2 CME.
Clinical Vignette #1: Dermatology Assessment
Your patient is a 42-year-old male with a history of obesity who presents with a persistent, itchy rash on his elbows and knees. On physical exam, you observe well-demarcated, erythematous plaques with an overlying silvery scale. When you attempt to scrape one of the scales, several small bleeding points appear.
Which of the following is the most likely diagnosis?
A. Atopic Dermatitis
B. Psoriasis Vulgaris
C. Tinea Corporis
D. Lichen Planus
Correct Answer: B. Psoriasis Vulgaris
Explanation: The clinical presentation of well-demarcated erythematous plaques with silvery scales is classic for Psoriasis Vulgaris. The bleeding points noted after scraping the scale are known as the Auspitz sign, which is highly suggestive of psoriasis.
- Atopic Dermatitis (A) typically presents as ill-defined, pruritic, erythematous patches in flexural areas (like the antecubital fossa), not the extensor surfaces like the elbows and knees.
- Tinea Corporis (C) would present as an annular (ring-shaped) lesion with central clearing and a raised border.
- Lichen Planus (D) is characterized by the "6 Ps": planar, purple, polygonal, pruritic, papules, and plaques, often involving the wrists and shins, but it does not typically show the silver scale or Auspitz sign.
Why "High-Yield" Matters for the Busy Clinician
As a PA, you don’t have time to sift through 50-page white papers on the molecular weight of modern statins. You need to know which statin to prescribe to the 65-year-old with a high ASCVD score and a history of myalgias.
Our courses, such as the Gastrointestinal Blueprint Review and the Pulmonary Blueprint Review, focus on the "must-know" facts that populate the NCCPA blueprints. We prioritize clinical pearls over academic filler.
By using your CME budget on a package that includes a $1,500 Apple Gift Card, you’re not just getting the 100 hours of credit you need to maintain your "C"; you’re also getting the hardware you need to consume that content efficiently.
A Note for Nurse Practitioners and Physicians
While our primary focus is the PA community, our Internal Medicine/Hospitalist and Cardiology content is used frequently by NPs and MDs. For NPs, AAPA Category 1 credit is accepted by the ANCC and AANP in most states, but you should always verify with your state board. For MDs and DOs, these hours generally count as Category 2 credit, which is still a vital part of your recertification and licensure maintenance.
Clinical Vignette #2: Cardiovascular Management
Your patient is a 68-year-old female with a history of HTN and Type 2 DM who presents to the ED with a sudden onset of palpitations and shortness of breath. Her HR is 142 bpm, BP is 112/74 mmHg, and SaO2 is 94% on room air. An ECG is performed immediately.
ECG Findings: The rhythm is irregularly irregular with a narrow QRS complex. There are no discernible P-waves.
What is the most appropriate next step in the management of this patient's rate control?
A. Immediate synchronized cardioversion
B. IV Diltiazem
C. IV Adenosine
D. PO Digoxin
Correct Answer: B. IV Diltiazem
Explanation: The patient is in Atrial Fibrillation with Rapid Ventricular Response (RVR). Since she is hemodynamically stable (BP 112/74), the goal is rate control. IV Diltiazem (a non-dihydropyridine calcium channel blocker) is a first-line agent for achieving rapid rate control in stable patients.
- Immediate synchronized cardioversion (A) is reserved for patients who are hemodynamically unstable (e.g., hypotension, altered mental status, signs of shock).
- IV Adenosine (C) is used for the treatment of stable supraventricular tachycardia (SVT), which would show a regular rhythm on ECG, not the irregularly irregular rhythm seen in AFib.
- PO Digoxin (D) is not appropriate for acute rate control in the ED setting due to its slow onset of action.
Maximizing Your "CME Money"
Let’s be real: your CME money is part of your total compensation package. If you don't use it, you're essentially taking a pay cut.
When you purchase a CME with Gift Card package, you are streamlining your administrative life. You get one receipt, one set of credits, and one significant perk.
The Blueprint Advantage
Our specialty reviews, like the Psychiatry Blueprint Review or the Neurology Blueprint Review, are designed to be consumed in chunks. We understand that you’re likely studying between patients or late at night after the kids have gone to bed. Our platform is mobile-friendly and easy to navigate, ensuring that your study time is as productive as possible.
Clinical Vignette #3: Infectious Disease
Your patient is a 24-year-old female presenting with a 3-day history of dysuria, urinary frequency, and urgency. She denies fever, chills, or flank pain. Her vital signs are stable. A urinalysis reveals positive nitrites and leukocyte esterase. She has no known drug allergies and has not been treated for a UTI in the past year.
Which of the following is the most appropriate first-line treatment?
A. Nitrofurantoin (Macrobid) 100mg BID for 5 days
B. Ciprofloxacin 500mg BID for 7 days
C. Ceftriaxone 250mg IM once
D. Doxycycline 100mg BID for 7 days
Correct Answer: A. Nitrofurantoin (Macrobid) 100mg BID for 5 days
Explanation: This patient has an uncomplicated urinary tract infection (cystitis). According to current guidelines, Nitrofurantoin (Macrobid) is a first-line treatment for uncomplicated cystitis.
- Ciprofloxacin (B) is effective but is no longer considered first-line for uncomplicated cystitis due to the risk of significant side effects (tendon rupture, C. diff) and the desire to preserve fluoroquinolones for more serious infections.
- Ceftriaxone (C) is typically used for pyelonephritis or more severe infections requiring parenteral therapy.
- Doxycycline (D) is not a primary treatment for cystitis; it is more commonly used for urethritis (e.g., Chlamydia).
Conclusion: Don't Let Your Allowance Go to Waste
The PANRE and your annual CME requirements don't have to be a source of stress. By choosing a provider that understands the practical needs of the modern Physician Assistant, you can knock out your credits, master the NCCPA blueprint, and walk away with a significant gift card add-on that makes the whole process a lot more palatable.
Check out our full range of courses today:
Spend your CME budget like a pro. Your career: and your Amazon cart( will thank you.)